INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 140 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2017. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,027,000 | -5.3% | 537,888 | +16.2% | 0.46% | -11.9% |
| Q2 2022 | $26,418,000 | -10.8% | 462,815 | -4.4% | 0.53% | +23.9% |
| Q1 2022 | $29,622,000 | -49.0% | 484,103 | -56.4% | 0.43% | -46.8% |
| Q4 2021 | $58,090,000 | +23.3% | 1,109,855 | -12.2% | 0.80% | +26.9% |
| Q3 2021 | $47,111,000 | +2.4% | 1,263,716 | +12.1% | 0.63% | -6.5% |
| Q2 2021 | $46,029,000 | -1.0% | 1,127,615 | -17.7% | 0.68% | +5.3% |
| Q1 2021 | $46,471,000 | -12.0% | 1,369,606 | -17.5% | 0.64% | -15.2% |
| Q4 2020 | $52,786,000 | +18.7% | 1,659,938 | -4.2% | 0.76% | -5.5% |
| Q3 2020 | $44,452,000 | -4.6% | 1,732,365 | -4.5% | 0.80% | -7.2% |
| Q2 2020 | $46,577,000 | +162.7% | 1,814,467 | +57.3% | 0.86% | +92.8% |
| Q1 2020 | $17,729,000 | +93.8% | 1,153,396 | +332.5% | 0.45% | +132.8% |
| Q4 2019 | $9,150,000 | +3.8% | 266,700 | -77.4% | 0.19% | -10.3% |
| Q3 2019 | $8,812,000 | -34.2% | 1,179,683 | +14.3% | 0.21% | -24.4% |
| Q2 2019 | $13,397,000 | -19.3% | 1,032,105 | -24.3% | 0.28% | -27.8% |
| Q1 2019 | $16,602,000 | +15.1% | 1,363,086 | +7.7% | 0.39% | +14.3% |
| Q4 2018 | $14,421,000 | -13.8% | 1,266,138 | +64.2% | 0.34% | -9.5% |
| Q3 2018 | $16,735,000 | -4.4% | 771,220 | -22.1% | 0.38% | -7.3% |
| Q2 2018 | $17,497,000 | +27.0% | 990,281 | +51.3% | 0.41% | +35.0% |
| Q1 2018 | $13,774,000 | -5.3% | 654,343 | -34.9% | 0.30% | -9.3% |
| Q4 2017 | $14,549,000 | +16.4% | 1,004,756 | +26.9% | 0.33% | +5.7% |
| Q3 2017 | $12,496,000 | +87.3% | 791,879 | +47.4% | 0.32% | +93.9% |
| Q2 2017 | $6,672,000 | +21.3% | 537,200 | +58.7% | 0.16% | +27.3% |
| Q1 2017 | $5,501,000 | – | 338,500 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |